FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992828030> ?p ?o ?g. }

• W1992828030 endingPage "2164" @default.
• W1992828030 startingPage "2158" @default.
• W1992828030 abstract "To investigate the concentrations and pharmacokinetics of ketorolac in the rabbits by three different routes of administrations: a single intracameral, intravitreal, and suprachoroidal injection.Fifty-four New Zealand white rabbits received ketorolac (250 μg/0.05 mL) in one eye by a single intracameral injection (group A, n = 18), single intravitreal injection (group B, n = 18), and single suprachoroidal injection (group C, n = 18). Drug concentrations in the vitreous, retina-choroid (RC), and plasma were determined by the methods of high-performance liquid chromatography at 0.5, 1, 2, 4, 8, and 24 hours after injection. The concentrations in the opposite eyes were also investigated.The mean maximum concentrations (Cmax) of ketorolac in the vitreous and RC were 0.378 ± 0.19 μg/mL and 3.15 ± 0.49 μg/g (at 0.5 hours), respectively, in group A; 156.2 ± 20.74 μg/mL (at 0.5 hours) and 208.0 ± 21.67 μg/g (at 1 hours), respectively, in group B; and 0.873 ± 0.34 μg/mL and 56.71 ± 22.64 μg/g (at 0.5 hours), respectively, in group C. In the RC, the area under the curve (AUC0-t) in group B (866.1 ± 52.67 μg/g·h) was higher (P < 0.01) than that in group C (77.10 ± 25.90 μg/g·h). The elimination half-life (t1/2) in group B (3.09 hours) was longer (P < 0.01) than that in group C (1.19 hours). In the control eyes, a drug level below 2 μg/g was detected in the RC in group C. Plasma concentrations were below 0.4 μg/mL in all 3 groups. Ketorolac was detectable in the RC till 24 hours after the intravitreal injection and 8 hours after the suprachoroidal injection.Intravitreal injection of ketorolac produced higher intraocular drug concentrations for a longer period compared with the other two routes. Suprachoroidal injection of ketorolac could reach an effective drug level in the RC with short half-lives and low drug levels in the vitreous. The plasma drug concentrations were low by all three routes." @default.
• W1992828030 created "2016-06-24" @default.
• W1992828030 creator A5004835414 @default.
• W1992828030 creator A5006014428 @default.
• W1992828030 creator A5009461931 @default.
• W1992828030 creator A5024851777 @default.
• W1992828030 creator A5039001559 @default.
• W1992828030 creator A5048189290 @default.
• W1992828030 creator A5053116914 @default.
• W1992828030 creator A5070508316 @default.
• W1992828030 creator A5073284583 @default.
• W1992828030 date "2012-11-01" @default.
• W1992828030 modified "2023-10-02" @default.
• W1992828030 title "PHARMACOKINETIC COMPARISON OF KETOROLAC AFTER INTRACAMERAL, INTRAVITREAL, AND SUPRACHOROIDAL ADMINISTRATION IN RABBITS" @default.
• W1992828030 cites W1963720039 @default.
• W1992828030 cites W1980642204 @default.
• W1992828030 cites W1981120553 @default.
• W1992828030 cites W1989756566 @default.
• W1992828030 cites W1992087811 @default.
• W1992828030 cites W1997322627 @default.
• W1992828030 cites W2011968199 @default.
• W1992828030 cites W2021871107 @default.
• W1992828030 cites W2032499340 @default.
• W1992828030 cites W2036811460 @default.
• W1992828030 cites W2039957409 @default.
• W1992828030 cites W2040283546 @default.
• W1992828030 cites W2040821535 @default.
• W1992828030 cites W2053261991 @default.
• W1992828030 cites W2057446483 @default.
• W1992828030 cites W2064358858 @default.
• W1992828030 cites W2079217070 @default.
• W1992828030 cites W2080524229 @default.
• W1992828030 cites W2083258563 @default.
• W1992828030 cites W2104662204 @default.
• W1992828030 cites W2107206676 @default.
• W1992828030 cites W2111546909 @default.
• W1992828030 cites W2126597960 @default.
• W1992828030 cites W2140225762 @default.
• W1992828030 cites W2145463304 @default.
• W1992828030 cites W2147842670 @default.
• W1992828030 cites W2158160240 @default.
• W1992828030 cites W2165781249 @default.
• W1992828030 cites W2168158846 @default.
• W1992828030 doi "https://doi.org/10.1097/iae.0b013e3182576d1d" @default.
• W1992828030 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23099451" @default.
• W1992828030 hasPublicationYear "2012" @default.
• W1992828030 type Work @default.
• W1992828030 sameAs 1992828030 @default.
• W1992828030 citedByCount "34" @default.
• W1992828030 countsByYear W19928280302012 @default.
• W1992828030 countsByYear W19928280302013 @default.
• W1992828030 countsByYear W19928280302014 @default.
• W1992828030 countsByYear W19928280302016 @default.
• W1992828030 countsByYear W19928280302017 @default.
• W1992828030 countsByYear W19928280302018 @default.
• W1992828030 countsByYear W19928280302019 @default.
• W1992828030 countsByYear W19928280302021 @default.
• W1992828030 countsByYear W19928280302022 @default.
• W1992828030 countsByYear W19928280302023 @default.
• W1992828030 crossrefType "journal-article" @default.
• W1992828030 hasAuthorship W1992828030A5004835414 @default.
• W1992828030 hasAuthorship W1992828030A5006014428 @default.
• W1992828030 hasAuthorship W1992828030A5009461931 @default.
• W1992828030 hasAuthorship W1992828030A5024851777 @default.
• W1992828030 hasAuthorship W1992828030A5039001559 @default.
• W1992828030 hasAuthorship W1992828030A5048189290 @default.
• W1992828030 hasAuthorship W1992828030A5053116914 @default.
• W1992828030 hasAuthorship W1992828030A5070508316 @default.
• W1992828030 hasAuthorship W1992828030A5073284583 @default.
• W1992828030 hasConcept C112705442 @default.
• W1992828030 hasConcept C118487528 @default.
• W1992828030 hasConcept C169760540 @default.
• W1992828030 hasConcept C185592680 @default.
• W1992828030 hasConcept C22979827 @default.
• W1992828030 hasConcept C2776694393 @default.
• W1992828030 hasConcept C2777093970 @default.
• W1992828030 hasConcept C2778446825 @default.
• W1992828030 hasConcept C2780820201 @default.
• W1992828030 hasConcept C42219234 @default.
• W1992828030 hasConcept C71924100 @default.
• W1992828030 hasConcept C86803240 @default.
• W1992828030 hasConcept C98274493 @default.
• W1992828030 hasConceptScore W1992828030C112705442 @default.
• W1992828030 hasConceptScore W1992828030C118487528 @default.
• W1992828030 hasConceptScore W1992828030C169760540 @default.
• W1992828030 hasConceptScore W1992828030C185592680 @default.
• W1992828030 hasConceptScore W1992828030C22979827 @default.
• W1992828030 hasConceptScore W1992828030C2776694393 @default.
• W1992828030 hasConceptScore W1992828030C2777093970 @default.
• W1992828030 hasConceptScore W1992828030C2778446825 @default.
• W1992828030 hasConceptScore W1992828030C2780820201 @default.
• W1992828030 hasConceptScore W1992828030C42219234 @default.
• W1992828030 hasConceptScore W1992828030C71924100 @default.
• W1992828030 hasConceptScore W1992828030C86803240 @default.
• W1992828030 hasConceptScore W1992828030C98274493 @default.
• W1992828030 hasIssue "10" @default.
• W1992828030 hasLocation W19928280301 @default.
• W1992828030 hasLocation W19928280302 @default.

• next